About Consultants for Clinical Research Inc.
Clinical Trials at Consultants for Clinical Research Inc.
During the past decade, Consultants for Clinical Research Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 17 clinical trials were completed, i.e. on
average, 113.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 12 clinical trials were completed. i.e. 1200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Consultants for Clinical Research Inc." #1 sponsor was "Shire" with 8 trials, followed by "Bausch Health Americas, Inc." with 3 trials
sponsored, "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Millennium Pharmaceuticals, Inc."
with 3 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Consultants for Clinical Research Inc."
#1 collaborator was "Cell Pathways" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "OSI Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Consultants for Clinical Research Inc.
According to Clinical.Site data, the most researched conditions in "Consultants for Clinical Research Inc." are
"Ulcerative Colitis" (11 trials), "Crohn's Disease" (8 trials), "Crohn Disease" (4 trials), "Eosinophilic Esophagitis (EoE)" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Consultants for Clinical Research Inc." in a lesser frequency.
Clinical Trials Intervention Types at Consultants for Clinical Research Inc.
Most popular intervention types in "Consultants for Clinical Research Inc." are "Drug" (25 trials), "Other" (7 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Ontamalimab" (4 trials), "vedolizumab" (3 trials), "Etrolizumab" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Consultants for Clinical Research Inc.
The vast majority of trials in "Consultants for Clinical Research Inc." are
27 trials for "All" genders.
Clinical Trials Status at Consultants for Clinical Research Inc.
Currently, there are NaN active trials in "Consultants for Clinical Research Inc.".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Consultants for Clinical Research Inc.,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Consultants for Clinical Research Inc., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".